Neurobiology of Aging
Volume 32, Issue 12 , Pages 2123-2130 , December 2011

Lack of association between 11C-PiB and longitudinal brain atrophy in non-demented older individuals

  • Ira Driscoll

      Affiliations

    • IRP, National Institute on Aging, NIH, United States
    • Corresponding Author InformationCorresponding author at: NIH Biomedical Research Center, 251 Bayview Blvd., Suite 100, Room #04B316, Baltimore, MD 21224, United States. Tel.: +1 410 558 8613; fax: +1 410 558 8674.
    • ,
  • Yun Zhou

      Affiliations

    • Department of Radiology, Johns Hopkins Medical Institutions, United States
    • ,
  • Yang An

      Affiliations

    • MedStar Research Institute, Baltimore, MD, United States
    • ,
  • Jitka Sojkova

      Affiliations

    • IRP, National Institute on Aging, NIH, United States
    • Department of Radiology, Johns Hopkins Medical Institutions, United States
    • ,
  • Christos Davatzikos

      Affiliations

    • Department of Radiology, University of Pennsylvania, United States
    • ,
  • Michael A. Kraut

      Affiliations

    • Department of Radiology, Johns Hopkins Medical Institutions, United States
    • ,
  • Weiguo Ye

      Affiliations

    • Department of Radiology, Johns Hopkins Medical Institutions, United States
    • ,
  • Luigi Ferrucci

      Affiliations

    • IRP, National Institute on Aging, NIH, United States
    • ,
  • Chester A. Mathis

      Affiliations

    • Department of Radiology, University of Pittsburgh, United States
    • ,
  • William E. Klunk

      Affiliations

    • Department of Psychiatry, University of Pittsburgh, United States
    • ,
  • Dean F. Wong

      Affiliations

    • Department of Radiology, Johns Hopkins Medical Institutions, United States
    • ,
  • Susan M. Resnick

      Affiliations

    • IRP, National Institute on Aging, NIH, United States
    • Address: NIH Biomedical Research Center, 251 Bayview Blvd, Room 4B317, Baltimore, MD 21224, United States.

Received 6 October 2009 ,Revised 25 November 2009 ,Accepted 8 December 2009.

References 

  1. Alzheimer A. Über einen eigenartigen schweren Krankheitsprozess der Hirnrinde. Neurologisches Centralblatt. 1906;25:1134
  2. Alzheimer A. Über eine eigenartige Erkrankung der Hirnrinde. Allgemeine Zeitschrift für Psychiatrie und psychisch-gerchtliche Medizin. 1907;64:146–148
  3. Bennett DA, Schneider JA, Arvanitakis Z, Kelly JF, Aggarwal NT, Shah RC, et al. Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology. 2006;66:1837–1844
  4. Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br. J. Psychiatry. 1968;114:797–811
  5. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol. 1991;82:239–259
  6. Braak H, Braak E. Evolution of neuronal changes in the course of Alzheimer's disease. J. Neural Transm. Suppl. 1998;53:127–140
  7. Davatzikos C, Genc A, Xu D, Resnick SM. Voxel-based morphometry using the RAVENS maps: methods and validation using simulated longitudinal atrophy. Neuroimage. 2001;14:1361–1369
  8. Driscoll I, Resnick SM, Troncoso JC, An Y, O’Brien R, Zonderman AB. Impact of Alzheimer's pathology on cognitive trajectories in nondemented elderly. Ann. Neurol. 2006;60:688–695
  9. Driscoll I, Davatzikos C, An Y, Wu X, Shen D, Kraut MA, et al. Longitudinal pattern of regional brain volume change differentiates normal aging from MCI. Neurology. 2009;72:1906–1913
  10. Fagan AM, Head D, Shah AR, Marcus D, Mintun M, Morris JC, et al. Decreased cerebrospinal fluid Abeta(42) correlates with brain atrophy in cognitively normal elderly. Ann. Neurol. 2009;65:176–183
  11. Fagan AM, Mintun MA, Mach RH, Lee SY, Dence CS, Shah AR, et al. Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans. Ann. Neurol. 2006;59:512–519
  12. Godbolt AK, Cipolotti L, Watt H, Fox NC, Janssen JC, Rossor MN. The natural history of Alzheimer disease: a longitudinal presymptomatic and symptomatic study of a familial cohort. Arch. Neurol. 2004;61:1743–1748
  13. Goldszal AF, Davatzikos C, Pham DL, Yan MX, Bryan RN, Resnick SM. An image-processing system for qualitative and quantitative volumetric analysis of brain images. J. Comput. Assist. Tomogr. 1998;22:827–837
  14. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science. 2002;297:353–356(review)
  15. Ingelsson M, Fukumoto H, Newell KL, Growdon JH, Hedley-Whyte ET, Frosch MP, et al. Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain. Neurology. 2004;62:925–931
  16. Jack CR, Lowe VJ, Senjem ML, Weigand SD, Kemp BJ, Shiung MM, et al. 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment. Brain. 2008;131:665–680
  17. Jack CR, Lowe VJ, Weigand SD, Wiste HJ, Senjem ML, Knopman DS, et al. Alzheimer's Disease Neuroimaging Initiative. Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease. Brain. 2009;132:1355–1365
  18. Kantarci K, Jack CR. Quantitative magnetic resonance techniques as surrogate markers of Alzheimer's disease. NeuroRx. 2004;1:196–205
  19. Kawas CH, Corrada MM, Brookmeyer R, Morrison A, Resnick SM, Zonderman AB, et al. Visual memory predicts Alzheimer's disease more than a decade before diagnosis. Neurology. 2003;60:1089–1093
  20. Kawas CH, Gray S, Brookmeyer R, Fozard J, Zonderman A. Age-specific incidence rates of Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology. 2000;54:2072–2077
  21. Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann. Neurol. 2004;55:306–319
  22. Mintun MA. Utilizing advanced imaging and surrogate markers across the spectrum of Alzheimer's disease. CNS Spectr. 2005;10:13–16
  23. Loening AM, Gambhir SS. AMIDE: a free software tool for multimodality medical image analysis. Mol. Imag. 2003;2:131–137
  24. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993;43:2412–2414
  25. Morris JC, Price AL. Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease. J. Mol. Neurosci. 2001;17:101–118(review)
  26. Ng SY, Villemagne VL, Masters CL, Rowe CC. Evaluating atypical dementia syndromes using positron emission tomography with carbon 11 labeled Pittsburgh Compound B. Arch. Neurol. 2007;64:1140–1144
  27. Nordberg A. Amyloid plaque imaging in vivo: current achievement and future prospects. Eur. J. Nucl. Med. Mol. Imaging. 2008;35:S46–S50(review)
  28. Petersen RC, Morris JC. Mild cognitive impairment as a clinical entity and treatment target. Arch. Neurol. 2005;62:1160–1163
  29. Price JL, Morris JC. Tangles and plaques in nondemented aging and “preclinical” Alzheimer's disease. Ann. Neurol. 1999;45:358–368
  30. Price JC, Klunk WE, Lopresti BJ, Lu X, Hoge JA, Ziolko SK, et al. Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B. J. Cereb. Blood Flow Metab. 2005;25:1528–1547
  31. Resnick SM, Goldszal AF, Davatzikos C, Golski S, Kraut MA, Metter EJ, et al. One-year age changes in MRI brain volumes in older adults. Cereb. Cortex. 2000;10:464–472
  32. Resnick SM, Pham DL, Kraut MA, Zonderman AB, Davatzikos C. Longitudinal magnetic resonance imaging studies of older adults: a shrinking brain. J. Neurosci. 2003;23:3295–3301
  33. Rowe CC, Ng S, Ackermann U, Gong SJ, Pike K, Savage G, et al. Imaging beta-amyloid burden in aging and dementia. Neurology. 2007;68:1718–1725
  34. Shen D, Davatzikos C. HAMMER: hierarchical attribute matching mechanism for elastic registration. IEEE Trans. Med. Imaging. 2002;21:1421–1439
  35. Thal DR, Braak H. Post-mortem diagnosis of Alzheimer's disease. Pathologe. 2005;26:201–213
  36. Torack RM. Adult dementia: history, biopsy, pathology. Neurosurgery. 1979;4(434):442
  37. Troncoso JC, Cataldo AM, Nixon RA, Barnett JL, Lee MK, Checler F, et al. Neuropathology of preclinical and clinical late-onset Alzheimer's disease. Ann. Neurol. 1998;43:673–676
  38. Villemagne VL, Pike KE, Darby D, Maruff P, Savage G, Ng S, et al. Abeta deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease. Neuropsychologia. 2008;46:1688–1697
  39. Zhou Y, Endres CJ, Brasic JR, Huang SC, Wong DF. Linear regression with spatial constraint to generate parametric images of ligand-receptor dynamic PET studies with a simplified reference tissue model. Neuroimage. 2003;18:975–989
  40. Zhou Y, Resnick SM, Ye W, Fan H, Holt DP, Klunk WE, et al. Using a reference tissue model with spatial constraint to quantify [11C]Pittsburgh Compound B PET for early diagnosis of Alzheimer's disease. Neuroimage. 2007;36:298–312

☆ GE Healthcare holds a license agreement with the University of Pittsburgh based on the PIB technology described in this manuscript. Dr. Klunk and Dr. Mathis are co-inventors of PIB and, as such, have a financial interest in this license agreement.

PII: S0197-4580(09)00400-X

doi: 10.1016/j.neurobiolaging.2009.12.008

Neurobiology of Aging
Volume 32, Issue 12 , Pages 2123-2130 , December 2011

Article Tools

* Image Usage & Resolution